Nuralogix Corp.’s Anura health platform has expanded its capabilities to predict health risks using transdermal optical imaging (TOI) technology to include fatty liver disease (FLD), which affects an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback